Cargando…

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)

Common cutaneous human papillomavirus (HPV) types induce skin warts, whereas species beta HPV are implicated, together with UV-radiation, in the development of non-melanoma skin cancer (NMSC) in immunosuppressed patients. Licensed HPV vaccines contain virus-like particles (VLP) self-assembled from L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huber, Bettina, Schellenbacher, Christina, Shafti-Keramat, Saeed, Jindra, Christoph, Christensen, Neil, Kirnbauer, Reinhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215943/ https://www.ncbi.nlm.nih.gov/pubmed/28056100 http://dx.doi.org/10.1371/journal.pone.0169533

Ejemplares similares

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

A Chimeric 18L1-45RG1 Virus-Like Particle Vaccine Cross-Protects against Oncogenic Alpha-7 Human Papillomavirus Types
por: Huber, Bettina, et al.
Publicado: (2015)

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach
por: Jindra, Christoph, et al.
Publicado: (2015)

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach
por: Jindra, Christoph, et al.
Publicado: (2015)

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
por: Huber, Bettina, et al.
Publicado: (2021)

Papillomavirus-like Particles in Equine Medicine
por: Hainisch, Edmund K., et al.
Publicado: (2023)

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
por: Ahmels, Melinda, et al.
Publicado: (2022)

Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
por: Handisurya, A, et al.
Publicado: (2016)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151
por: Kovanda, Anja, et al.
Publicado: (2011)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalence
por: Namujju, Proscovia B, et al.
Publicado: (2011)

Human Papillomavirus Type16- L1 VLP Production in Insect Cells
por: Abdoli, Asghar, et al.
Publicado: (2013)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP
por: Roldão, António, et al.
Publicado: (2012)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
por: Janitzek, Christoph M., et al.
Publicado: (2019)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Characterization of a Novel Cutaneous Human Papillomavirus Genotype HPV-125
por: Kovanda, Anja, et al.
Publicado: (2011)

Systematic Review and Meta-Analysis of L1-VLP-Based Human Papillomavirus Vaccine Efficacy against Anogenital Pre-Cancer in Women with Evidence of Prior HPV Exposure
por: Miltz, Ada, et al.
Publicado: (2014)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

Deficiency of Cathelicidin-related Antimicrobial Peptide Promotes Skin Papillomatosis in Mus musculus Papillomavirus 1-infected Mice
por: DORFER, Sonja, et al.
Publicado: (2021)

Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
por: Schumacher, Jens, et al.
Publicado: (2018)

Natural History of Cutaneous Human Papillomavirus (HPV) Infection in Men: The HIM Study
por: Hampras, Shalaka S., et al.
Publicado: (2014)

Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany
por: Loenenbach, Anna, et al.
Publicado: (2022)

Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming
por: Viscidi, Raphael P., et al.
Publicado: (2023)

Design of a Novel and Potent Multi-Epitope Chimeric Vaccine against Human Papillomavirus (HPV): An Immunoinformatics Approach
por: Shahab, Muhammad, et al.
Publicado: (2023)

Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus
por: Cladel, Nancy M., et al.
Publicado: (2022)

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions
por: Antanasijevic, Aleksandar, et al.
Publicado: (2016)

Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
por: Naupu, Paulina N., et al.
Publicado: (2020)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature
por: Peabody, Julianne, et al.
Publicado: (2017)

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
por: Mahumud, Rashidul Alam, et al.
Publicado: (2020)

Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types
por: Kwak, Kihyuck, et al.
Publicado: (2014)

A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
por: Wolf, Tobias, et al.
Publicado: (2022)

Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus
por: Mobini, Saeed, et al.
Publicado: (2020)

Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines
por: Ye, Ling, et al.
Publicado: (2011)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5iueqoigev2b9agajc3tqj7p0